Ibuprofen API Market Analysis

  • Report ID: 5471
  • Published Date: May 09, 2025
  • Report Format: PDF, PPT

Ibuprofen API Industry Segmentation

Application (Headache, Arthritis)

The arthritis segment in the ibuprofen API market is projected to gather the largest share of about 60% by 2037. This could be owing to the growing prevalence of arthritis. Millions of people globally suffer from arthritis. Approximately 1 in 5 individuals in the US have a medically diagnosed case of arthritis. Extreme joint pain brought on by arthritis may render it difficult for patients to engage in daily activities. Their ability to work, engage in healthy physical activity, and maintain their mental health may all be impacted by this. Hence, the demand for ibuprofen active pharmaceutical ingredient (API) is growing. Rheumatoid arthritis and other inflammatory arthritis can be treated with higher dosages of ibuprofen, which are prescribed. Ibuprofen is equally effective as aspirin along with other nonsteroidal anti-inflammatory medications (NSAIDs) in treating rheumatoid arthritis. Ibuprofen contrasts positively to other NSAIDs and has a tolerability and safety profile that is superior to that of aspirin. 

End-User (CROs & CMOs, Pharmaceutical & Biopharmaceutical Companies)

The pharmaceutical & biopharmaceutical companies segment is expected to hold 60% share of the global ibuprofen API market during the forecast period. There has been a surge in the development of pharmaceutical & biopharmaceutical companies due to which the development of ibuprofen API is rising. Additionally, the investment made by the government is also high in this sector which is why the manufacturing of medications is carried out at an expanded ratio. Additionally, more prevalence is given to biopharmaceutical companies as a result of the combination of biopharmaceutical products' safety, efficacy, and ability to cure illnesses that were previously incurable. For instance, ibuprofen is a class IIa medication (low solubility, high permeability) in the Biopharmaceutics Classification System (BCS) that is used as an anti-inflammatory, analgesic, and antipyretic.

Our in-depth analysis of the global ibuprofen API market includes the following segments:

          Application

  • Headache
  • Arthritis

          End-User

  • CROs & CMOs
  • Pharmaceutical & Biopharmaceutical Companies

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

Ibuprofen API Market in 2025 is evaluated at USD 727.67 million.

The global market size was more than USD 715.08 million in 2024 and is anticipated to grow at a CAGR of around 2.2%, reaching USD 948.89 million revenue by 2037.

Asia Pacific is expected to yield USD 332.11 million by 2037, driven by low manufacturing cost of medicines and increasing health expenditure in the region.

The major players in the market include Azelis, Lonza, BIOCAUSE Inc., IOL Chemicals and Pharmaceuticals Limited.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos